3 employees
Delonix Bioworks is working on synthetic biology approaches to develop the next generation medical solutions for infectious diseases.
2020
$14M
from 2 investors over 2 rounds
Delonix Bioworks raised $14M on March 11, 2021
Investors: ZhenFund 真格基金 and IDG Capital Partners